Clinical trial
Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia
NCT07357935 is registered in ClinicalTrials.gov with Qingyuan Zhan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia
- Lead sponsor
- Qingyuan Zhan
- Phase
- Phase 1/2
- Overall status
- Not yet recruiting
- Start date
- February 1, 2026
- Completion date
- October 1, 2028
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
acute respiratory failure, community-acquired pneumonia